The interplay between oat beta glucan, gut microbiota and gut-liver axis in treatment of obesity associated non-alcoholic steatohepatitis and Type II diabetes mellitus. IJBB [Internet]. 2023 Jun. 16 [cited 2026 Sep. 23];59(1):14-22. Available from: https://op.niscpr.res.in/index.php/IJBB/article/view/2796